New scientists (364 Ergebnisse)

Zustand: acceptable. This copy has clearly been enjoyedâ"expect noticeable shelf wear and some minor creases to the cover. Binding is strong, and all pages are legible. May contain previous library markings or stamps.

Paperback. Zustand: Very Good. Drug development, the processes by which a chemical compound becomes a drug and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent protections impose an ever-contracting timeframe for success. Written to be accessible to a wide audience, NEW DRUGS provides a thorough, succinct, and practical understanding of these drug-development processes. If you're involved in the pharmaceutical industry, NEW DRUGS will provide scientific and management tools to increase the likelihood of regulatory approval at each phase of your compound's development. If you're a patient or consumer, NEW DRUGS will enable you to intelligently discuss medications with your health-care provider and empower you to make informed decisions at the pharmacy. If your portfolio, rather than your health, makes you an interested observer of the fortunes of this critical sector of the US economy, NEW DRUGS will help you to decode press releases and annual reports, so that you can recognize and invest in well-run companies with promising products.…

Paperback. Zustand: Good. Drug development, the processes by which a chemical compound becomes a drug and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent protections impose an ever-contracting timeframe for success. Written to be accessible to a wide audience, NEW DRUGS provides a thorough, succinct, and practical understanding of these drug-development processes. If you're involved in the pharmaceutical industry, NEW DRUGS will provide scientific and management tools to increase the likelihood of regulatory approval at each phase of your compound's development. If you're a patient or consumer, NEW DRUGS will enable you to intelligently discuss medications with your health-care provider and empower you to make informed decisions at the pharmacy. If your portfolio, rather than your health, makes you an interested observer of the fortunes of this critical sector of the US economy, NEW DRUGS will help you to decode press releases and annual reports, so that you can recognize and invest in well-run companies with promising products. …

Paperback. Zustand: Fair. Many young Christians interested in the sciences have felt torn between two options: remaining faithful to Christ or studying science. Heated debates over the past century have created the impression that we have to choose between one or the other. The result has been a crisis of faith for many students. Josh Reeves and Steve Donaldson present a concise introduction to the study of science that explains why scientists in every age have found science congenial to their faith and how Christians in the sciences can bridge the gap between science and Christian belief and practice. If Christians are to have a beneficial dialogue with science, it will be guided by those who understand science from the inside. Consequently, this book provides both advice and encouragement for Christians entering or engaged in scientific careers because their presence in science is a vital component of the church's witness in the world.…

Paperback. Zustand: Good. Many young Christians interested in the sciences have felt torn between two options: remaining faithful to Christ or studying science. Heated debates over the past century have created the impression that we have to choose between one or the other. The result has been a crisis of faith for many students. Josh Reeves and Steve Donaldson present a concise introduction to the study of science that explains why scientists in every age have found science congenial to their faith and how Christians in the sciences can bridge the gap between science and Christian belief and practice. If Christians are to have a beneficial dialogue with science, it will be guided by those who understand science from the inside. Consequently, this book provides both advice and encouragement for Christians entering or engaged in scientific careers because their presence in science is a vital component of the church's witness in the world.…

Hardcover. Zustand: Very Good. With dust jacket. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Paperback. Zustand: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Paperback. Zustand: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Paperback. Zustand: Good. Addressing fundamental questions about life, this unique volume examines the way in which distinguished scientists of different faiths explore the connections between science, ethics, spirituality and the divine.

Hardback. Zustand: Very Good. For more than half a century, medical advances have been driven by investigators launching experiments inside labs. Science is often conducted in isolation and geared toward the long view. This is the story of a group of people who tried to force the lab doors open: parents whose children had been diagnosed with a rare and fatal genetic condition known as Niemann-Pick disease type C. The disease prevents cells from processing cholesterol, which leads to the progressive loss of the brain's and the body's ability to function. Recognizing that there would never be a treatment in time to save their children if things stayed the same, the parents set up a collaboration with researchers and doctors in search of a cure. Reconciling different views of science took work. The parents, doctors, and researchers didn't always agree - among themselves or with each other. But together they endeavored to accelerate the development of new drugs. The parents became citizen scientists, identifying promising new treatments and helping devise experiments. They recorded data about the children and co-authored scientific papers sharing findings. They engaged directly with the FDA at each step of the drug approval process. Along the way, they advanced the radical idea that science must belong to us all. Amy Dockser Marcus shows what happens when a community joins forces with doctors and researchers to try to save children's lives. Their extraordinary social experiment reveals new pathways for treating disease and conducting research. Science may be forever changed. …

Hardback. Zustand: Fair. For more than half a century, medical advances have been driven by investigators launching experiments inside labs. Science is often conducted in isolation and geared toward the long view. This is the story of a group of people who tried to force the lab doors open: parents whose children had been diagnosed with a rare and fatal genetic condition known as Niemann-Pick disease type C. The disease prevents cells from processing cholesterol, which leads to the progressive loss of the brain's and the body's ability to function. Recognizing that there would never be a treatment in time to save their children if things stayed the same, the parents set up a collaboration with researchers and doctors in search of a cure. Reconciling different views of science took work. The parents, doctors, and researchers didn't always agree - among themselves or with each other. But together they endeavored to accelerate the development of new drugs. The parents became citizen scientists, identifying promising new treatments and helping devise experiments. They recorded data about the children and co-authored scientific papers sharing findings. They engaged directly with the FDA at each step of the drug approval process. Along the way, they advanced the radical idea that science must belong to us all. Amy Dockser Marcus shows what happens when a community joins forces with doctors and researchers to try to save children's lives. Their extraordinary social experiment reveals new pathways for treating disease and conducting research. Science may be forever changed.…

Hardback. Zustand: Good. The fascinating story of the hidden world of bird-breeding, of contentious ideas in 1920s Germany, and of two amateur scientists who unwittingly managed to be decades ahead of their time. Long before Dolly the Sheep or bioengineered corn, there was the Red Canary-the first organism to be manipulated by genetic technology, back in the 1920s. The effort to produce a red canary invoked all of the deep issues that troubled genetic engineering decades later: the nature of genes and how they work, the specter of eugenics, and the relative roles of nature and nurture in determining what an organism is. Behavioral ecologist Tim Birkhead describes how a sweet-voiced green bird discovered by Spanish explorers in the 1300s became a craze in Renaissance Europe, how breeders gradually turned its green plumage to yellow, and how a pair of German scientists used the first bit of gene technology in the 1920s to produce an almost-red canary. But the true red canary would not come until the 1960s, when British scientists successfully bred one, and genes alone would not be sufficient to create one. A Brand New Bird is a compelling tale of a fascinating episode in the history of genetics.…

Mass Market Paperback. Zustand: Fair. Reissue. The item might be beaten up but readable. May contain markings or highlighting, as well as stains, bent corners, or any other major defect, but the text is not obscured in any way.

Hardcover. Zustand: Very Good. With dust jacket. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Hardcover. Zustand: Very Good. With dust jacket. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

hardcover. Zustand: Very Good. Very Good Condition - May show some limited signs of wear and may have a remainder mark. Pages and dust cover are intact and not marred by notes or highlighting.

Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Hardback. Zustand: Good. John Sibbick (illustrator).

Hardback. Zustand: Very Good. John Sibbick (illustrator).

Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Hardback. Zustand: Good. Join herpetologist Eli Greenbaum on his race to identify a multitude of unidentified species in the Congo, a volatile African region overcome with population pressure, military oppression, and climate change. These are the backdrop challenges to the science pursued by Dr. Greenbaum in this timely work worthy of Darwin. Venomous River chronicles a field scientist's search for new species in the Congo Basin, one of the world's great crucibles of biodiversity, in the face of climate change. Although tropical forests cover less than 10 percent of Earth's land surface, they are home to about two-thirds of the planet's terrestrial biodiversity. Unfortunately, a ballooning human population has severely damaged half of the planet's pristine ecosystems and the biodiversity they contained, leading to an unfolding sixth mass extinction. In Joseph Conrad's famous 1899 novella Heart of Darkness, he described the Congo River as "a great snake." More than a century later, herpetologist, evolutionary biologist, and seasoned expedition leader Eli Greenbaum set out to find the Democratic Republic of the Congo's (Congo for short) incredible diversity of serpents in the flesh, along with the country's rarest frogs, lizards, crocodiles, and turtles, which live in and along Africa's second-largest river. For a biologist, an expedition into the heart of the Congo is a priceless gift, with its incredible species, known and unknown, lurking around every bend in the river. But the Congo is also a place of endemic political instability, widespread corruption, human suffering, and extraordinary danger. These, as much as the challenges of the natural world, confront any scientist doing field work in the Congo. Venomous River is the harrowing story of a biodiversity scientist's successful quest to discover several new amphibian and reptile species in the remotest heart of Africa, a wilderness where he encounters friendly peoples, a cook who is revealed to be a dangerous killer, highly venomous snakes and scorpions, deadly tropical diseases, and troubling echoes of the Congo's colonial history. …

Hardcover. Zustand: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Zustand: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.